BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cho SY. Patient-derived xenografts as compatible models for precision oncology. Lab Anim Res 2020;36:14. [PMID: 32461927 DOI: 10.1186/s42826-020-00045-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Bian S. Modeling Brain Tumors Using Genetically Edited Brain Organoids. Neuromethods 2023. [DOI: 10.1007/978-1-0716-2720-4_9] [Reference Citation Analysis]
2 Shin J, Piao Y, Bang D, Kim S, Jo K. DRPreter: Interpretable Anticancer Drug Response Prediction Using Knowledge-Guided Graph Neural Networks and Transformer. IJMS 2022;23:13919. [DOI: 10.3390/ijms232213919] [Reference Citation Analysis]
3 Michael N, Nilubol N. Bridging the Scientific Gaps to Identify Effective Treatments in Adrenocortical Cancer. Cancers 2022;14:5245. [DOI: 10.3390/cancers14215245] [Reference Citation Analysis]
4 Xiang K, Wang E, Rupprecht G, Mantyh J, Negrete M, Sanati G, Hsu C, Randon P, Dohlman A, Kretzschmar K, Giroux N, Ding S, Wang L, Balcazar JP, Huang Q, Sundaramoorthy P, Xi R, Mccall SJ, Wang Z, Kang Y, Kopetz S, Crawford GE, Clevers H, Hsu D, Shen X. Chromatin Remodeling in Patient-Derived Colorectal Cancer Models.. [DOI: 10.1101/2022.07.24.501300] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Oswald E, Bug D, Grote A, Lashuk K, Bouteldja N, Lenhard D, Löhr A, Behnke A, Knauff V, Edinger A, Klingner K, Gaedicke S, Niedermann G, Merhof D, Feuerhake F, Schueler J. Immune cell infiltration pattern in non-small cell lung cancer PDX models is a model immanent feature and correlates with a distinct molecular and phenotypic make-up. J Immunother Cancer 2022;10:e004412. [PMID: 35483746 DOI: 10.1136/jitc-2021-004412] [Reference Citation Analysis]
6 Hakuno SK, Michiels E, Kuhlemaijer EB, Rooman I, Hawinkels LJAC, Slingerland M. Multicellular Modelling of Difficult-to-Treat Gastrointestinal Cancers: Current Possibilities and Challenges. Int J Mol Sci 2022;23:3147. [PMID: 35328567 DOI: 10.3390/ijms23063147] [Reference Citation Analysis]
7 Shin H, Lee E, Yang W, Kim HS, Chung D, Cho H, Kim J. Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models. Cancers 2022;14:829. [DOI: 10.3390/cancers14030829] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
8 Avdoshina DV, Kondrashova AS, Belikova MG, Bayurova EO. Murine Models of Chronic Viral Infections and Associated Cancers. Mol Biol 2022;56:649-67. [PMID: 36217336 DOI: 10.1134/S0026893322050028] [Reference Citation Analysis]
9 Goncharova AS, Shevchenko AN, Dashkova IR, Anisimov AE. Methodological aspects of creation of patient-derived tumor xenografts. Kazan Med J 2021;102:694-702. [DOI: 10.17816/kmj2021-694] [Reference Citation Analysis]
10 Strüder D, Momper T, Irmscher N, Krause M, Liese J, Schraven S, Zimpfer A, Zonnur S, Burmeister AS, Schneider B, Frerich B, Mlynski R, Große-Thie C, Junghanss C, Maletzki C. Establishment and characterization of patient-derived head and neck cancer models from surgical specimens and endoscopic biopsies. J Exp Clin Cancer Res 2021;40:246. [PMID: 34362423 DOI: 10.1186/s13046-021-02047-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
11 Mattei F, Andreone S, Mencattini A, De Ninno A, Businaro L, Martinelli E, Schiavoni G. Oncoimmunology Meets Organs-on-Chip. Front Mol Biosci 2021;8:627454. [PMID: 33842539 DOI: 10.3389/fmolb.2021.627454] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
12 Dupont CA, Riegel K, Pompaiah M, Juhl H, Rajalingam K. Druggable genome and precision medicine in cancer: current challenges. FEBS J 2021. [PMID: 33626231 DOI: 10.1111/febs.15788] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
13 Akter F, Simon B, de Boer NL, Redjal N, Wakimoto H, Shah K. Pre-clinical tumor models of primary brain tumors: Challenges and opportunities. Biochim Biophys Acta Rev Cancer 2021;1875:188458. [PMID: 33148506 DOI: 10.1016/j.bbcan.2020.188458] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]